Longitudinal trends of and factors associated with inappropriate antibiotic prescribing for non-bacterial acute respiratory tract infection in Japan: A retrospective claims database study, 2012-2017.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 18 06 2019
accepted: 29 09 2019
entrez: 17 10 2019
pubmed: 17 10 2019
medline: 17 3 2020
Statut: epublish

Résumé

Inappropriate antibiotic prescribing is a cause of antimicrobial resistance. Acute Respiratory Tract Infections (ARTI) are common diseases for those antibiotics are most likely prescribed in outpatient setting. To clarify factors associated with antibiotic prescribing for non-bacterial acute respiratory tract infections (NB-ARTI) and identify targets for reducing inappropriate prescribing for NB-ARTI in Japan. We conducted a retrospective, observational study using longitudinal claims data between April 2012 and June 2017. We assessed the rate of and factors associated with inappropriate antibiotic prescribing in outpatient settings for all NB-ARTI consultations included in the database. The mean monthly antibiotic prescribing rate per 100 NB-ARTI consultations during the study period was 31.65. The monthly antibiotic prescribing rate per 100 NB-ARTI consultations decreased by 19.2% from April 2012 to June 2017. Adolescents (13-18 years) and adults of working age (19-29 and 30-39 years) were more likely prescribed antibiotics compared with elderly patients ≥ 60 years (aOR: 1.493 [95%CI: 1.482-1.503], 1.585 [95%CI: 1.575-1.595], and 1.507 [95%CI: 1.498-1.516], respectively). Outpatient clinics registered as internal medicine or ear, nose, and throat specialty were more likely to prescribe antibiotics than those of paediatric specialty or other specialties. Among health facility type, clinics without beds (aOR 2.123 [95%CI: 2.113-2.133]) and clinics with beds (aOR: 1.752 [95%CI: 1.7371-1.767]) prescribed significantly more antibiotics for NB-ARTI than outpatient departments inside general hospitals. Inappropriate antibiotic prescribing for NB-ARTI is common in Japan. Although the antibiotic prescribing rate has decreased, further interventions are required to promote antimicrobial stewardship (ASP). Education and awareness for adults and promotion of ASP among physicians in clinics without beds are key drivers to reduce inappropriate antibiotic prescribing in Japan.

Sections du résumé

BACKGROUND
Inappropriate antibiotic prescribing is a cause of antimicrobial resistance. Acute Respiratory Tract Infections (ARTI) are common diseases for those antibiotics are most likely prescribed in outpatient setting.
OBJECTIVES
To clarify factors associated with antibiotic prescribing for non-bacterial acute respiratory tract infections (NB-ARTI) and identify targets for reducing inappropriate prescribing for NB-ARTI in Japan.
METHODS
We conducted a retrospective, observational study using longitudinal claims data between April 2012 and June 2017. We assessed the rate of and factors associated with inappropriate antibiotic prescribing in outpatient settings for all NB-ARTI consultations included in the database.
RESULTS
The mean monthly antibiotic prescribing rate per 100 NB-ARTI consultations during the study period was 31.65. The monthly antibiotic prescribing rate per 100 NB-ARTI consultations decreased by 19.2% from April 2012 to June 2017. Adolescents (13-18 years) and adults of working age (19-29 and 30-39 years) were more likely prescribed antibiotics compared with elderly patients ≥ 60 years (aOR: 1.493 [95%CI: 1.482-1.503], 1.585 [95%CI: 1.575-1.595], and 1.507 [95%CI: 1.498-1.516], respectively). Outpatient clinics registered as internal medicine or ear, nose, and throat specialty were more likely to prescribe antibiotics than those of paediatric specialty or other specialties. Among health facility type, clinics without beds (aOR 2.123 [95%CI: 2.113-2.133]) and clinics with beds (aOR: 1.752 [95%CI: 1.7371-1.767]) prescribed significantly more antibiotics for NB-ARTI than outpatient departments inside general hospitals.
CONCLUSIONS
Inappropriate antibiotic prescribing for NB-ARTI is common in Japan. Although the antibiotic prescribing rate has decreased, further interventions are required to promote antimicrobial stewardship (ASP). Education and awareness for adults and promotion of ASP among physicians in clinics without beds are key drivers to reduce inappropriate antibiotic prescribing in Japan.

Identifiants

pubmed: 31618258
doi: 10.1371/journal.pone.0223835
pii: PONE-D-19-17056
pmc: PMC6795458
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Comparative Study Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0223835

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS One. 2018 Oct 24;13(10):e0204878
pubmed: 30356302
JAMA Netw Open. 2018 Jun 1;1(2):e180243
pubmed: 30646067
J Public Health (Oxf). 2018 Jun 1;40(2):397-403
pubmed: 28453710
J Antimicrob Chemother. 2014 Jan;69(1):234-40
pubmed: 23887867
Ir J Med Sci. 2018 Nov;187(4):969-986
pubmed: 29532292
PLoS One. 2013 Dec 23;8(12):e84177
pubmed: 24376793
Int J Med Inform. 2018 Mar;111:131-139
pubmed: 29425624
J Glob Antimicrob Resist. 2016 Aug 6;7:19-23
pubmed: 27973324
Infect Drug Resist. 2018 Nov 08;11:2199-2205
pubmed: 30519057
J Med Internet Res. 2011 Dec 14;13(4):e110
pubmed: 22169526
Ann Intern Med. 2017 Jun 6;166(11):765-774
pubmed: 28492914
JAMA. 2016 May 3;315(17):1864-73
pubmed: 27139059
Eur J Public Health. 2017 Jun 1;27(3):506-512
pubmed: 27836969
J Antimicrob Chemother. 2019 Feb 1;74(2):515-520
pubmed: 30445465
Antibiotics (Basel). 2017 Oct 31;6(4):null
pubmed: 29088074
Scand J Prim Health Care. 2017 Jun;35(2):178-185
pubmed: 28569649
PLoS One. 2018 Nov 5;13(11):e0207017
pubmed: 30395640
CMAJ Open. 2018 Oct 31;6(4):E445-E452
pubmed: 30381321
Fam Pract. 2015 Aug;32(4):401-7
pubmed: 25911505
J Infect Chemother. 2018 Jun;24(6):414-421
pubmed: 29428566
Soc Sci Med. 2017 Oct;191:89-98
pubmed: 28917140
BMJ Open. 2016 Oct 24;6(10):e012244
pubmed: 27798010
J Antimicrob Chemother. 2018 Oct 1;73(10):2883-2892
pubmed: 29955785
BMJ. 2018 Nov 12;363:k3047
pubmed: 30420401
Fam Pract. 2019 Jul 31;36(4):402-409
pubmed: 30272148
Intern Med. 2009;48(16):1369-75
pubmed: 19687581

Auteurs

Yuki Kimura (Y)

AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.

Haruhisa Fukuda (H)

AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.
Department of Health Care Administration and Management, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.

Kayoko Hayakawa (K)

AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.
Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.

Satoshi Ide (S)

Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.

Masayuki Ota (M)

Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.

Sho Saito (S)

Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.

Masahiro Ishikane (M)

AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.
Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.

Yoshiki Kusama (Y)

AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.

Nobuaki Matsunaga (N)

AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.

Norio Ohmagari (N)

AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.
Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH